

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.20923956 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.83299193 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.83299193 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.82681639 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.45842407 |
| 6 | type I interferon signaling pathway (GO:0060337) | 4.45510087 |
| 7 | cellular response to type I interferon (GO:0071357) | 4.45510087 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.43457652 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.42942609 |
| 10 | response to type I interferon (GO:0034340) | 4.41532970 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.30587489 |
| 12 | immunoglobulin mediated immune response (GO:0016064) | 4.26929960 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.16182558 |
| 14 | negative regulation of interleukin-12 production (GO:0032695) | 4.10578747 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 4.02310141 |
| 16 | T cell migration (GO:0072678) | 3.93880629 |
| 17 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.90358387 |
| 18 | negative thymic T cell selection (GO:0045060) | 3.71671642 |
| 19 | negative T cell selection (GO:0043383) | 3.68109776 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.63701488 |
| 21 | positive thymic T cell selection (GO:0045059) | 3.60014916 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 3.58131668 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.57690421 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 3.57690421 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.57690421 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.57690421 |
| 27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.57690421 |
| 28 | modulation by symbiont of host immune response (GO:0052553) | 3.57690421 |
| 29 | negative regulation of T cell mediated immunity (GO:0002710) | 3.50510818 |
| 30 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.47928686 |
| 31 | regulation of T cell tolerance induction (GO:0002664) | 3.47519486 |
| 32 | response to peptidoglycan (GO:0032494) | 3.47200597 |
| 33 | response to interferon-beta (GO:0035456) | 3.44383511 |
| 34 | leukocyte aggregation (GO:0070486) | 3.44138918 |
| 35 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.43997291 |
| 36 | macrophage activation involved in immune response (GO:0002281) | 3.42209374 |
| 37 | cellular response to interleukin-15 (GO:0071350) | 3.41663391 |
| 38 | response to interleukin-15 (GO:0070672) | 3.41637712 |
| 39 | detection of other organism (GO:0098543) | 3.40952525 |
| 40 | defense response to protozoan (GO:0042832) | 3.40598930 |
| 41 | regulation of interferon-alpha production (GO:0032647) | 3.39444130 |
| 42 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.38202873 |
| 43 | B cell mediated immunity (GO:0019724) | 3.35650888 |
| 44 | detection of bacterium (GO:0016045) | 3.35596839 |
| 45 | positive regulation of antigen processing and presentation (GO:0002579) | 3.25387351 |
| 46 | regulation of tolerance induction (GO:0002643) | 3.25285916 |
| 47 | regulation of antigen processing and presentation (GO:0002577) | 3.24351553 |
| 48 | positive regulation of interferon-alpha production (GO:0032727) | 3.24280059 |
| 49 | positive T cell selection (GO:0043368) | 3.23867239 |
| 50 | negative regulation of viral genome replication (GO:0045071) | 3.23696402 |
| 51 | response to interferon-alpha (GO:0035455) | 3.22913356 |
| 52 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.21414841 |
| 53 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.21001777 |
| 54 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.17413521 |
| 55 | response to protozoan (GO:0001562) | 3.16271405 |
| 56 | regulation of regulatory T cell differentiation (GO:0045589) | 3.15487841 |
| 57 | positive regulation of tolerance induction (GO:0002645) | 3.12342146 |
| 58 | T cell selection (GO:0045058) | 3.10181092 |
| 59 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.09406773 |
| 60 | interferon-gamma production (GO:0032609) | 3.06834693 |
| 61 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.06690799 |
| 62 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.05025888 |
| 63 | cellular response to interferon-gamma (GO:0071346) | 3.03754780 |
| 64 | tolerance induction (GO:0002507) | 3.03604098 |
| 65 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.03280766 |
| 66 | regulation of B cell differentiation (GO:0045577) | 3.02862747 |
| 67 | thymic T cell selection (GO:0045061) | 3.02234223 |
| 68 | positive regulation of B cell differentiation (GO:0045579) | 3.01507506 |
| 69 | positive regulation of defense response to virus by host (GO:0002230) | 3.01319850 |
| 70 | B cell receptor signaling pathway (GO:0050853) | 2.99606388 |
| 71 | positive regulation of type 2 immune response (GO:0002830) | 2.95656389 |
| 72 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.95318919 |
| 73 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.89672966 |
| 74 | detection of external biotic stimulus (GO:0098581) | 2.88746342 |
| 75 | cellular extravasation (GO:0045123) | 2.88663316 |
| 76 | response to interferon-gamma (GO:0034341) | 2.88611620 |
| 77 | neutrophil activation (GO:0042119) | 2.88464490 |
| 78 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.88134392 |
| 79 | myeloid cell activation involved in immune response (GO:0002275) | 2.86868191 |
| 80 | regulation of interleukin-12 production (GO:0032655) | 2.86054436 |
| 81 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.85509180 |
| 82 | interferon-gamma secretion (GO:0072643) | 2.82609147 |
| 83 | mast cell activation (GO:0045576) | 2.82544464 |
| 84 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.82239650 |
| 85 | microglial cell activation (GO:0001774) | 2.81292640 |
| 86 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.80338522 |
| 87 | response to host immune response (GO:0052572) | 2.80338522 |
| 88 | NIK/NF-kappaB signaling (GO:0038061) | 2.79650040 |
| 89 | granulocyte activation (GO:0036230) | 2.79607196 |
| 90 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.79107556 |
| 91 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.79107556 |
| 92 | germinal center formation (GO:0002467) | 2.78752748 |
| 93 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.78567279 |
| 94 | T-helper cell differentiation (GO:0042093) | 2.77879977 |
| 95 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.77879977 |
| 96 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.77434260 |
| 97 | activated T cell proliferation (GO:0050798) | 2.77278720 |
| 98 | response to muramyl dipeptide (GO:0032495) | 2.76434195 |
| 99 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.75698526 |
| 100 | lymphocyte chemotaxis (GO:0048247) | 2.75392863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.66160495 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.89417105 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.84654273 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.58995597 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.52233144 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.94123492 |
| 7 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.72526717 |
| 8 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.06187615 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.99170382 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.97974749 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.89029687 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70560083 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 2.70016541 |
| 14 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.54962062 |
| 15 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.37402868 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34638924 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.19433750 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.16504877 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.16167036 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.14925448 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.13540699 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12430807 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 2.03795649 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.95649466 |
| 25 | GATA3_26560356_Chip-Seq_TH2_Human | 1.94842554 |
| 26 | * MAF_26560356_Chip-Seq_TH1_Human | 1.92372370 |
| 27 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.90216724 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.88790774 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.86852186 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.79836877 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77987517 |
| 32 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76915177 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.76267880 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74061518 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.71998611 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55335125 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48603748 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48451640 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47183998 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45969698 |
| 41 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.44926926 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44641051 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38097375 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.34851181 |
| 45 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34664208 |
| 46 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.34496679 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34325139 |
| 48 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33756210 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33304786 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.32019990 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27455495 |
| 52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23335799 |
| 53 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.21626737 |
| 54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19484240 |
| 55 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.19364694 |
| 56 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.17785539 |
| 57 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.15512008 |
| 58 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.15053129 |
| 59 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11238889 |
| 60 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11208875 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10507255 |
| 62 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.06439083 |
| 63 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02720196 |
| 64 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01913490 |
| 65 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.01725688 |
| 66 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00704967 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00167714 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97450093 |
| 69 | MYC_22102868_ChIP-Seq_BL_Human | 0.96823297 |
| 70 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.96784450 |
| 71 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94742547 |
| 72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92590495 |
| 73 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90494419 |
| 74 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86280317 |
| 75 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.85261728 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83441002 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81371008 |
| 78 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81307075 |
| 79 | GATA3_26560356_Chip-Seq_TH1_Human | 0.80424501 |
| 80 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.79265635 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79088999 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78824826 |
| 83 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.77373501 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76490149 |
| 85 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76423030 |
| 86 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.74580440 |
| 87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.73316860 |
| 88 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.72258404 |
| 89 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71869105 |
| 90 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71171451 |
| 91 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.70040685 |
| 92 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.69328961 |
| 93 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.68712319 |
| 94 | * P300_27268052_Chip-Seq_Bcells_Human | 0.68605024 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.67199445 |
| 96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.65350512 |
| 97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.64689897 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64187630 |
| 99 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64118052 |
| 100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.63897204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.31175333 |
| 2 | MP0003724_increased_susceptibility_to | 4.29174957 |
| 3 | MP0005671_abnormal_response_to | 3.72904281 |
| 4 | MP0003436_decreased_susceptibility_to | 3.46877017 |
| 5 | MP0003303_peritoneal_inflammation | 3.37617643 |
| 6 | MP0009785_altered_susceptibility_to | 3.35741167 |
| 7 | MP0005387_immune_system_phenotype | 3.22911920 |
| 8 | MP0001790_abnormal_immune_system | 3.22911920 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.15356870 |
| 10 | MP0001800_abnormal_humoral_immune | 3.13033244 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 3.02108085 |
| 12 | MP0000685_abnormal_immune_system | 2.91282043 |
| 13 | MP0006082_CNS_inflammation | 2.80993721 |
| 14 | MP0005025_abnormal_response_to | 2.80506855 |
| 15 | MP0002723_abnormal_immune_serum | 2.75516529 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.68108079 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.64968001 |
| 18 | MP0002419_abnormal_innate_immunity | 2.64241073 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.51058338 |
| 20 | MP0001819_abnormal_immune_cell | 2.49319100 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.15489983 |
| 22 | MP0010155_abnormal_intestine_physiology | 2.14403434 |
| 23 | MP0002405_respiratory_system_inflammati | 2.00703866 |
| 24 | MP0001533_abnormal_skeleton_physiology | 1.97919823 |
| 25 | MP0001845_abnormal_inflammatory_respons | 1.93447591 |
| 26 | MP0000716_abnormal_immune_system | 1.90168640 |
| 27 | MP0002398_abnormal_bone_marrow | 1.87326222 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.85510121 |
| 29 | MP0009764_decreased_sensitivity_to | 1.81136135 |
| 30 | MP0004947_skin_inflammation | 1.71677816 |
| 31 | MP0008469_abnormal_protein_level | 1.64393058 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.60678919 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.58609720 |
| 34 | MP0003866_abnormal_defecation | 1.54008128 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.53837709 |
| 36 | MP0001873_stomach_inflammation | 1.53810869 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.51565653 |
| 38 | MP0002722_abnormal_immune_system | 1.49724794 |
| 39 | MP0005310_abnormal_salivary_gland | 1.46541500 |
| 40 | MP0002429_abnormal_blood_cell | 1.45878709 |
| 41 | MP0001853_heart_inflammation | 1.38096187 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.35086288 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.34654341 |
| 44 | MP0003183_abnormal_peptide_metabolism | 1.30469727 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.30215335 |
| 46 | MP0003075_altered_response_to | 1.25012352 |
| 47 | MP0002006_tumorigenesis | 1.19863426 |
| 48 | MP0009278_abnormal_bone_marrow | 1.15444394 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.15134967 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.15134967 |
| 51 | MP0002933_joint_inflammation | 1.13449919 |
| 52 | MP0005166_decreased_susceptibility_to | 1.13261832 |
| 53 | MP0004510_myositis | 1.12952350 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.12921840 |
| 55 | MP0000858_altered_metastatic_potential | 1.11583343 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.11420832 |
| 57 | MP0003195_calcinosis | 1.05740290 |
| 58 | MP0002254_reproductive_system_inflammat | 1.04227371 |
| 59 | MP0005164_abnormal_response_to | 1.01822181 |
| 60 | MP0003448_altered_tumor_morphology | 0.99682450 |
| 61 | MP0002998_abnormal_bone_remodeling | 0.98545543 |
| 62 | MP0004381_abnormal_hair_follicle | 0.96197281 |
| 63 | MP0005058_abnormal_lysosome_morphology | 0.95339368 |
| 64 | MP0004883_abnormal_blood_vessel | 0.95321623 |
| 65 | MP0000343_altered_response_to | 0.94348939 |
| 66 | MP0006054_spinal_hemorrhage | 0.94302691 |
| 67 | MP0009763_increased_sensitivity_to | 0.94019156 |
| 68 | MP0002132_abnormal_respiratory_system | 0.92400526 |
| 69 | MP0003828_pulmonary_edema | 0.92111617 |
| 70 | MP0003045_fibrosis | 0.91997777 |
| 71 | MP0001663_abnormal_digestive_system | 0.91872521 |
| 72 | MP0001851_eye_inflammation | 0.86182092 |
| 73 | MP0003806_abnormal_nucleotide_metabolis | 0.83938372 |
| 74 | MP0005075_abnormal_melanosome_morpholog | 0.83864456 |
| 75 | MP0005451_abnormal_body_composition | 0.82574357 |
| 76 | MP0005390_skeleton_phenotype | 0.81904248 |
| 77 | MP0000604_amyloidosis | 0.79375453 |
| 78 | MP0002693_abnormal_pancreas_physiology | 0.75717160 |
| 79 | MP0008260_abnormal_autophagy | 0.75197079 |
| 80 | MP0009765_abnormal_xenobiotic_induced | 0.72766141 |
| 81 | MP0008004_abnormal_stomach_pH | 0.72391404 |
| 82 | MP0002332_abnormal_exercise_endurance | 0.72305941 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 0.72177749 |
| 84 | MP0001501_abnormal_sleep_pattern | 0.71342094 |
| 85 | MP0000249_abnormal_blood_vessel | 0.70914598 |
| 86 | MP0009840_abnormal_foam_cell | 0.68049225 |
| 87 | MP0001542_abnormal_bone_strength | 0.67669472 |
| 88 | MP0002396_abnormal_hematopoietic_system | 0.66396149 |
| 89 | MP0003252_abnormal_bile_duct | 0.64896839 |
| 90 | MP0003690_abnormal_glial_cell | 0.63193383 |
| 91 | MP0000569_abnormal_digit_pigmentation | 0.62258771 |
| 92 | MP0003795_abnormal_bone_structure | 0.61343673 |
| 93 | MP0005319_abnormal_enzyme/_coenzyme | 0.61152949 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 0.58545322 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.58205108 |
| 96 | MP0004808_abnormal_hematopoietic_stem | 0.58079037 |
| 97 | MP0001986_abnormal_taste_sensitivity | 0.57900404 |
| 98 | MP0001764_abnormal_homeostasis | 0.56261420 |
| 99 | MP0000015_abnormal_ear_pigmentation | 0.54948392 |
| 100 | MP0005535_abnormal_body_temperature | 0.54340818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 5.45096748 |
| 2 | Myositis (HP:0100614) | 5.12764437 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 5.08878976 |
| 4 | Optic neuritis (HP:0100653) | 5.08878976 |
| 5 | Orchitis (HP:0100796) | 4.97179389 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.78680929 |
| 7 | Eczematoid dermatitis (HP:0000976) | 4.70214254 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.44023027 |
| 9 | Recurrent abscess formation (HP:0002722) | 4.23696248 |
| 10 | T lymphocytopenia (HP:0005403) | 4.21502202 |
| 11 | Abnormality of T cell number (HP:0011839) | 4.17511275 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.08910018 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.98699097 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.83484850 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.82917650 |
| 16 | Vasculitis (HP:0002633) | 3.81593531 |
| 17 | Meningitis (HP:0001287) | 3.78228027 |
| 18 | Pulmonary infiltrates (HP:0002113) | 3.75755122 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.71404946 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.71404946 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 3.68153362 |
| 22 | Increased IgM level (HP:0003496) | 3.66457084 |
| 23 | Hemoptysis (HP:0002105) | 3.56288731 |
| 24 | Encephalitis (HP:0002383) | 3.53371471 |
| 25 | Keratoconjunctivitis sicca (HP:0001097) | 3.52639627 |
| 26 | Abnormality of T cells (HP:0002843) | 3.43910990 |
| 27 | Keratoconjunctivitis (HP:0001096) | 3.42678971 |
| 28 | Recurrent skin infections (HP:0001581) | 3.36634345 |
| 29 | Recurrent viral infections (HP:0004429) | 3.32266328 |
| 30 | IgG deficiency (HP:0004315) | 3.28285631 |
| 31 | Obstructive lung disease (HP:0006536) | 3.23687090 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 3.23687090 |
| 33 | Panhypogammaglobulinemia (HP:0003139) | 3.23377628 |
| 34 | Autoimmune hemolytic anemia (HP:0001890) | 3.23075089 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.14711471 |
| 36 | Abnormality of B cell number (HP:0010975) | 3.08026823 |
| 37 | Recurrent bronchitis (HP:0002837) | 3.07121644 |
| 38 | Gangrene (HP:0100758) | 2.90294605 |
| 39 | Leukocytosis (HP:0001974) | 2.88355218 |
| 40 | Autoimmune thrombocytopenia (HP:0001973) | 2.85469635 |
| 41 | Agammaglobulinemia (HP:0004432) | 2.85362870 |
| 42 | Abnormality of T cell physiology (HP:0011840) | 2.82085732 |
| 43 | Eosinophilia (HP:0001880) | 2.81954719 |
| 44 | Pustule (HP:0200039) | 2.78045581 |
| 45 | Abnormality of the prostate (HP:0008775) | 2.76168144 |
| 46 | Arterial thrombosis (HP:0004420) | 2.75414869 |
| 47 | Chest pain (HP:0100749) | 2.75153070 |
| 48 | Chronic diarrhea (HP:0002028) | 2.71384598 |
| 49 | Pulmonary embolism (HP:0002204) | 2.67305890 |
| 50 | Granulocytopenia (HP:0001913) | 2.66436079 |
| 51 | Abnormality of the pleura (HP:0002103) | 2.65016113 |
| 52 | B lymphocytopenia (HP:0010976) | 2.62179927 |
| 53 | Severe combined immunodeficiency (HP:0004430) | 2.57123975 |
| 54 | Abnormality of eosinophils (HP:0001879) | 2.56579403 |
| 55 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.54295143 |
| 56 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.54295143 |
| 57 | Abnormality of glycolipid metabolism (HP:0010969) | 2.54295143 |
| 58 | Hypergammaglobulinemia (HP:0010702) | 2.52829522 |
| 59 | Anorexia (HP:0002039) | 2.52358872 |
| 60 | Lymphopenia (HP:0001888) | 2.47423707 |
| 61 | Urticaria (HP:0001025) | 2.46937243 |
| 62 | Increased IgE level (HP:0003212) | 2.44455944 |
| 63 | Chronic otitis media (HP:0000389) | 2.43276489 |
| 64 | Stomach cancer (HP:0012126) | 2.38740656 |
| 65 | Recurrent sinusitis (HP:0011108) | 2.36476027 |
| 66 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.34820719 |
| 67 | Gingivitis (HP:0000230) | 2.31906773 |
| 68 | Joint swelling (HP:0001386) | 2.29037795 |
| 69 | Spontaneous hematomas (HP:0007420) | 2.27946111 |
| 70 | Systemic lupus erythematosus (HP:0002725) | 2.24946930 |
| 71 | Thyroiditis (HP:0100646) | 2.22279717 |
| 72 | Hematochezia (HP:0002573) | 2.21966592 |
| 73 | Inflammation of the large intestine (HP:0002037) | 2.21862649 |
| 74 | Polyneuropathy (HP:0001271) | 2.21803179 |
| 75 | Increased cerebral lipofuscin (HP:0011813) | 2.21720774 |
| 76 | Prostate neoplasm (HP:0100787) | 2.21569751 |
| 77 | Prolonged bleeding time (HP:0003010) | 2.20513228 |
| 78 | Petechiae (HP:0000967) | 2.19920705 |
| 79 | Epistaxis (HP:0000421) | 2.17628821 |
| 80 | Episodic fever (HP:0001954) | 2.17125587 |
| 81 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.14007222 |
| 82 | Abnormality of the pericardium (HP:0001697) | 2.10906604 |
| 83 | Keratitis (HP:0000491) | 2.09459479 |
| 84 | Alveolar cell carcinoma (HP:0006519) | 2.09193619 |
| 85 | Gastrointestinal stroma tumor (HP:0100723) | 2.08806423 |
| 86 | Glomerulopathy (HP:0100820) | 2.07960200 |
| 87 | Cellulitis (HP:0100658) | 2.07953602 |
| 88 | Skin rash (HP:0000988) | 2.07541432 |
| 89 | Hypochromic anemia (HP:0001931) | 2.07422545 |
| 90 | Gingival bleeding (HP:0000225) | 2.06358041 |
| 91 | Vacuolated lymphocytes (HP:0001922) | 2.04083889 |
| 92 | Combined immunodeficiency (HP:0005387) | 2.03736167 |
| 93 | Gastrointestinal inflammation (HP:0004386) | 2.03380912 |
| 94 | Colitis (HP:0002583) | 2.01287741 |
| 95 | Abnormality of iron homeostasis (HP:0011031) | 2.00912718 |
| 96 | IgM deficiency (HP:0002850) | 1.95993767 |
| 97 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.95981148 |
| 98 | Bronchitis (HP:0012387) | 1.95410633 |
| 99 | IgA deficiency (HP:0002720) | 1.95288491 |
| 100 | Increased serum ferritin (HP:0003281) | 1.94172915 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.74509943 |
| 2 | TXK | 4.23558343 |
| 3 | RIPK4 | 3.10913738 |
| 4 | TYK2 | 2.88174989 |
| 5 | MAP3K14 | 2.87163851 |
| 6 | BLK | 2.64850649 |
| 7 | IKBKE | 2.53753417 |
| 8 | TAOK3 | 2.43564222 |
| 9 | JAK3 | 2.32508921 |
| 10 | IKBKB | 2.22198937 |
| 11 | FES | 2.18879287 |
| 12 | IRAK4 | 2.14008111 |
| 13 | SYK | 2.10889989 |
| 14 | CSK | 2.08324760 |
| 15 | ZAP70 | 2.06065578 |
| 16 | TBK1 | 2.02198406 |
| 17 | BTK | 1.97665873 |
| 18 | JAK1 | 1.97119725 |
| 19 | KIT | 1.92387560 |
| 20 | ITK | 1.87870725 |
| 21 | TEC | 1.79913781 |
| 22 | BMPR2 | 1.76995212 |
| 23 | GRK6 | 1.73765807 |
| 24 | FRK | 1.72560986 |
| 25 | TNK2 | 1.71518891 |
| 26 | ERN1 | 1.69059237 |
| 27 | LYN | 1.52800224 |
| 28 | GRK7 | 1.46400761 |
| 29 | CSF1R | 1.42163702 |
| 30 | LCK | 1.41681176 |
| 31 | MAP3K13 | 1.35640033 |
| 32 | HCK | 1.35118063 |
| 33 | ADRBK2 | 1.35008486 |
| 34 | MAP2K3 | 1.26004755 |
| 35 | MATK | 1.15330076 |
| 36 | NLK | 1.14224191 |
| 37 | JAK2 | 1.11953754 |
| 38 | IRAK1 | 1.05978920 |
| 39 | PRPF4B | 1.05877405 |
| 40 | MAP3K3 | 1.04322218 |
| 41 | SIK3 | 1.03269790 |
| 42 | IRAK3 | 1.03034187 |
| 43 | FGFR3 | 1.02084480 |
| 44 | PRKCQ | 0.95620855 |
| 45 | TGFBR2 | 0.94943508 |
| 46 | MAP3K11 | 0.92430030 |
| 47 | CHUK | 0.90145727 |
| 48 | FGR | 0.89094584 |
| 49 | CAMKK2 | 0.84360581 |
| 50 | HIPK2 | 0.82592724 |
| 51 | FGFR4 | 0.80931601 |
| 52 | MARK3 | 0.79860844 |
| 53 | MAP2K6 | 0.78086933 |
| 54 | STK10 | 0.77052414 |
| 55 | PIK3CG | 0.77035710 |
| 56 | PDK1 | 0.73990991 |
| 57 | EPHB1 | 0.69736241 |
| 58 | PIM1 | 0.69582363 |
| 59 | TLK1 | 0.69093110 |
| 60 | MAP3K12 | 0.65247713 |
| 61 | EPHA3 | 0.63353263 |
| 62 | ACVR1B | 0.63325350 |
| 63 | CDC42BPA | 0.62339047 |
| 64 | TRPM7 | 0.60744210 |
| 65 | TAOK2 | 0.60526881 |
| 66 | NME2 | 0.59501039 |
| 67 | MAP2K2 | 0.57903256 |
| 68 | MST4 | 0.57350588 |
| 69 | MAP3K1 | 0.57279155 |
| 70 | KDR | 0.55132425 |
| 71 | MAPK7 | 0.54278126 |
| 72 | MAPK11 | 0.49940106 |
| 73 | ABL1 | 0.49586277 |
| 74 | TAOK1 | 0.48102508 |
| 75 | MAP3K5 | 0.46272404 |
| 76 | PINK1 | 0.43133568 |
| 77 | MAP3K7 | 0.41797146 |
| 78 | DAPK2 | 0.40583505 |
| 79 | FYN | 0.40510275 |
| 80 | GRK1 | 0.40122488 |
| 81 | NUAK1 | 0.38960796 |
| 82 | PTK2B | 0.37611941 |
| 83 | ADRBK1 | 0.37143660 |
| 84 | GRK5 | 0.35054274 |
| 85 | MAPKAPK2 | 0.34747806 |
| 86 | EGFR | 0.30685942 |
| 87 | PDPK1 | 0.30474301 |
| 88 | PRKCD | 0.30158510 |
| 89 | IGF1R | 0.29521421 |
| 90 | LRRK2 | 0.28841012 |
| 91 | RPS6KA5 | 0.28609558 |
| 92 | INSR | 0.28076792 |
| 93 | CAMKK1 | 0.27187180 |
| 94 | IRAK2 | 0.26834847 |
| 95 | TESK2 | 0.26679305 |
| 96 | MELK | 0.26434161 |
| 97 | RIPK1 | 0.26176419 |
| 98 | MOS | 0.26166815 |
| 99 | MAP4K2 | 0.25761387 |
| 100 | CDK4 | 0.23784972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.94294368 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.79818699 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.56068143 |
| 4 | Asthma_Homo sapiens_hsa05310 | 3.36568513 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.23679093 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.15849625 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.07702340 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.99403639 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.84265866 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.81997561 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.51636209 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.23358444 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22866219 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.06631230 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.02769265 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.01055787 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.00006963 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.96077995 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.88713391 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.87853906 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.85788322 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.83358666 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.80211680 |
| 24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.74391312 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68862175 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.62827077 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.61908873 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.60113562 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52241269 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.46449523 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.45021552 |
| 32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.41039554 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.37207513 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.35329182 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.23362822 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17265714 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.08916714 |
| 38 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.07439291 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04878038 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 0.95888121 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95583919 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92010099 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 0.91336958 |
| 44 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86821486 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 0.83148175 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 0.81470968 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.78120734 |
| 48 | Platelet activation_Homo sapiens_hsa04611 | 0.68916328 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.67172556 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 0.66578414 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.65044169 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62968745 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62200468 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60745704 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60700792 |
| 56 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56338806 |
| 57 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55416026 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46800166 |
| 59 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45223546 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44197848 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42866125 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42252863 |
| 63 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41829446 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41444964 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39935656 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.39153064 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35544624 |
| 68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33890318 |
| 69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.32594642 |
| 70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.31506253 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29060581 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.28340525 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.27455399 |
| 74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.26184928 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24860541 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24126683 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.23380559 |
| 78 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21888427 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.21604131 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.21238348 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20622773 |
| 82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.18682935 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.17087230 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17074420 |
| 85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.16745297 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.16067797 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15978570 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.15763815 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.15215134 |
| 90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.13048943 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.10093608 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.09258222 |
| 93 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.09233684 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.08927317 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.08068304 |
| 96 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.07601058 |
| 97 | Phototransduction_Homo sapiens_hsa04744 | 0.05651333 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.05289101 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.03927403 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.03657411 |

